334
Views
6
CrossRef citations to date
0
Altmetric
Research Article

A combined compression molding, heating, and leaching process for fabrication of micro-porous poly(ε-caprolactone) scaffolds

, , &
Pages 1978-1993 | Received 27 Apr 2018, Accepted 06 Jul 2018, Published online: 30 Oct 2018

References

  • Loh QL, Choong C. Three-dimensional scaffolds for tissue engineering applications: role of porosity and pore size. Tissue Eng Part B Rev. 2013;19:485–502.
  • Zhang N, Wang Y, Xu WP, et al. Poly(lactide-co-glycolide)/Hydroxyapatite porous scaffold with microchannels for bone regeneration. Polymers. 2016;8:218.
  • Wu J, Zhang KX, Yu X, et al. Hydration of hydrogels regulates vascularization in vivo. Biomat Sci. 2017;5:2251–2267.
  • Ulery BD, Nair LS, Laurencin CT. Biomedical Applications of Biodegradable Polymers. J Polym Sci B Polym Phys. 2011;49:832–864.
  • Bi M, Han H, Dong SJ, et al. Collagen-Coated Poly(lactide-co-glycolide)/Hydroxyapatite Scaffold incorporated with DGEA Peptide for synergistic repair of skull defect. Polymers. 2018;10:109.
  • Kim JB, Stein R, O'Hare MJ. Three-dimensional in vitro tissue culture models of breast cancer—a review. Breast Cancer Res Treat. 2004;85:281–291.
  • Nyga A, Cheema U, Loizidou M. 3D tumour models: novel in vitro approaches to cancer studies. J Cell Commun Signal. 2011;5:239–248.
  • Kim JB. Three-dimensional tissue culture models in cancer biology. Semin Cancer Biol. 2005;15:365–377.
  • Sahoo SK, Panda AK, Labhasetwar V. Characterization of porous PLGA/PLA microparticles as a scaffold for three dimensional growth of breast cancer cells. Biomacromolecules. 2005;6:1132–1139.
  • Oh SH, Park IK, Kim JM, et al. In vitro and in vivo characteristics of PCL scaffolds with pore size gradient fabricated by a centrifugation method. Biomaterials. 2007;28:1664–1671.
  • O'Brien FJ, Harley BA, Yannas IV, et al. The effect of pore size on cell adhesion in collagen-GAG scaffolds. Biomaterials. 2005;26:433–441.
  • Malikmammadov E, Tanir TE, Kiziltay A, et al. PCL and PCL-based materials in biomedical applications. J Biomater Sci Polym Ed. 2018;29(7–9):863–893.
  • Shor L, Guceri S, Wen X, et al. Fabrication of three-dimensional polycaprolactone/hydroxyapatite tissue scaffolds and osteoblast-scaffold interactions in vitro. Biomaterials. 2007;28:5291–5297.
  • Sarasam A, Madihally SV. Characterization of chitosan-polycaprolactone blends for tissue engineering applications. Biomaterials. 2005;26:5500–5508.
  • Pankajakshan D, Philipose LP, Palakkal M, et al. Development of a fibrin composite-coated poly(epsilon-caprolactone) scaffold for potential vascular tissue engineering applications. J Biomed Mater Res B Appl Biomater. 2008;87:570–579.
  • Lee MY, Tsai WW, Chen HJ, et al. Laser sintered porous polycaprolacone scaffolds loaded with hyaluronic acid and gelatin-grafted thermoresponsive hydrogel for cartilage tissue engineering. Biomed Mater Eng. 2013;23:533–543.
  • Wang SJ, Zhang ZZ, Jiang D, et al. Thermogel-Coated Poly(epsilon-Caprolactone) composite Scaffold for enhanced cartilage tissue engineering. Polymers. 2016;8:200.
  • Zhang ZZ, Wang SJ, Zhang JY, et al. 3D-Printed Poly(epsilon-caprolactone) Scaffold augmented with mesenchymal stem cells for total meniscal substitution: A 12-and 24-week animal study in a Rabbit Model. Am J Sports Med. 2017;45:1497–1511.
  • Chen H, Huang J, Yu J, et al. Electrospun chitosan-graft-poly (epsilon -caprolactone)/poly (epsilon-caprolactone) cationic nanofibrous mats as potential scaffolds for skin tissue engineering. Int J Biol Macromol. 2011;48:13–19.
  • Bolaina-Lorenzo E, Martinez-Ramos C, Monleon-Pradas M, et al. Electrospun polycaprolactone/chitosan scaffolds for nerve tissue engineering: physicochemical characterization and Schwann cell biocompatibility. Biomed Mater. 2016;12:015008.
  • Williamson MR, Black R, Kielty C. PCL-PU composite vascular scaffold production for vascular tissue engineering: attachment, proliferation and bioactivity of human vascular endothelial cells. Biomaterials. 2006;27:3608–3616.
  • Rai B, Teoh SH, Hutmacher DW, et al. Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2. Biomaterials. 2005;26:3739–3748.
  • Kim HW, Knowles JC, Kim HE. Hydroxyapatite/poly(epsilon-caprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery. Biomaterials. 2004;25:1279–1287.
  • Moghadam MZ, Hassanajili S, Esmaeilzadeh F, et al. Formation of porous HPCL/LPCL/HA scaffolds with supercritical CO2 gas foaming method. J Mech Behav Biomed Mat. 2017;69:115–127.
  • Yeong WY, Sudarmadji N, Yu HY, et al. Porous polycaprolactone scaffold for cardiac tissue engineering fabricated by selective laser sintering. Acta Biomater. 2010;6:2028–2034.
  • Venugopal J, Ma LL, Yong T, et al. In vitro study of smooth muscle cells on polycaprolactone and collagen nanofibrous matrices. Cell Biol Int. 2005;29:861–867.
  • Asvar Z, Mirzaei E, Azarpira N, et al. Evaluation of electrospinning parameters on the tensile strength and suture retention strength of polycaprolactone nanofibrous scaffolds through surface response methodology. J Mech Behav Biomed Mater. 2017;75:369–378.
  • Rao SS, Nelson MT, Xue R, et al. Mimicking white matter tract topography using core-shell electrospun nanofibers to examine migration of malignant brain tumors. Biomaterials. 2013;34:5181–5190.
  • Li WJ, Laurencin CT, Caterson EJ, et al. Electrospun nanofibrous structure: a novel scaffold for tissue engineering. J Biomed Mater Res. 2002;60:613–621.
  • Baker SC, Rohman G, Southgate J, et al. The relationship between the mechanical properties and cell behaviour on PLGA and PCL scaffolds for bladder tissue engineering. Biomaterials. 2009;30:1321–1328.
  • Loordhuswamy AM, Krishnaswamy VR, Korrapati PS, et al. Fabrication of highly aligned fibrous scaffolds for tissue regeneration by centrifugal spinning technology. Mater Sci Eng C Mater Biol Appl. 2014;42:799–807.
  • Zhang J, Liu H, Ding JX, et al. High-pressure compression-molded porous resorbable polymer/hydroxyapatite composite Scaffold for cranial bone regeneration. ACS Biomat Sci Eng. 2016;2:1471–1482.
  • Hutmacher DW, Schantz T, Zein I, et al. Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. J Biomed Mater Res. 2001;55:203–216.
  • Zhang ZZ, Jiang D, Ding JX, et al. Role of scaffold mean pore size in meniscus regeneration. Acta Biomaterialia. 2016;43:314–326.
  • Huang A, Jiang YC, Napiwocki B, et al. Fabrication of poly(epsilon-caprolactone) tissue engineering scaffolds with fibrillated and interconnected pores utilizing microcellular injection molding and polymer leaching. RSC Adv. 2017;7:43432–43444.
  • Intranuovo F, Gristina R, Brun F, et al. Plasma modification of PCL Porous Scaffolds fabricated by solvent-casting/particulateleaching for tissue engineering. Plasma Proc Polym. 2014;11:184–195.
  • Yang Q, Chen L, Shen XY, et al. Preparation of polycaprolactone tissue engineering scaffolds by improved solvent casting/particulate leaching method. J Macromol Sci Part B-Phys. 2006;45:1171–1181.
  • Thadavirul N, Pavasant P, Supaphol P. Development of polycaprolactone porous scaffolds by combining solvent casting, particulate leaching, and polymer leaching techniques for bone tissue engineering. J Biomed Mat Res Part A. 2014;102:3379–3392.
  • Zhou CC, Yang K, Wang KF, et al. Combination of fused deposition modeling and gas foaming technique to fabricated hierarchical macro/microporous polymer scaffolds. Mat Design. 2016;109:415–424.
  • Kanimozhi K, Basha SK, Kumari VS, et al. Development of biomimetic hybrid porous Scaffold of Chitosan/Polyvinyl Alcohol/Carboxymethyl cellulose by freeze-dried and salt leached technique. J Nanosci Nanotechnol. 2018;18:4916–4922.
  • Salerno A, Zeppetelli S, Di Maio E, et al. Processing/Structure/Property relationship of multi-scaled PCL and PCL-HA composite Scaffolds prepared via gas foaming and NaCl reverse templating. Biotechnol Bioeng. 2011;108:963–976.
  • Gentile P, Chiono V, Carmagnola I, et al. An overview of poly(lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering. Int J Mol Sci. 2014;15:3640–3659.
  • Rao SS, Bushnell GG, Azarin SM, et al. Enhanced survival with implantable Scaffolds that capture metastatic breast cancer cells in vivo. Cancer Res. 2016;76:5209–5218.
  • Thadavirul N, Pavasant P, Supaphol P. Development of polycaprolactone porous scaffolds by combining solvent casting, particulate leaching, and polymer leaching techniques for bone tissue engineering. J Biomed Mater Res A. 2014;102:3379–3392.
  • Aguado BA, Caffe JR, Nanavati D, et al. Extracellular matrix mediators of metastatic cell colonization characterized using scaffold mimics of the pre-metastatic niche. Acta Biomater. 2016;33:13–24.
  • Moghadam MZ, Hassanajili S, Esmaeilzadeh F, et al. Formation of porous HPCL/LPCL/HA scaffolds with supercritical CO2 gas foaming method. J Mech Behav Biomed Mater. 2017;69:115–127.
  • Riddle KW, Mooney DJ. Role of poly(lactide-co-glycolide) particle size on gas-foamed scaffolds. J Biomater Sci Polym Ed. 2004;15:1561–1570.
  • Balachander GM, Balaji SA, Rangarajan A, et al. Enhanced metastatic potential in a 3D tissue Scaffold toward a comprehensive in vitro model for breast cancer metastasis. ACS Appl Mater Interfaces. 2015;7:27810–27822.
  • Yu H, Matthew HW, Wooley PH, et al. Effect of porosity and pore size on microstructures and mechanical properties of poly-epsilon-caprolactone- hydroxyapatite composites. J Biomed Mater Res B Appl Biomater. 2008;86:541–547.
  • Correia AL, Bissell MJ. The tumor microenvironment is a dominant force in multidrug resistance. Drug Resist Updat. 2012;15:39–49.
  • Paszek MJ, Zahir N, Johnson KR, et al. Tensional homeostasis and the malignant phenotype. Cancer Cell. 2005;8:241–254.
  • Sims-Mourtada J, Niamat RA, Samuel S, et al. Enrichment of breast cancer stem-like cells by growth on electrospun polycaprolactone-chitosan nanofiber scaffolds. Int J Nanomed. 2014;9:995–1003.
  • Palomeras S, Rabionet M, Ferrer I, et al. Breast cancer stem cell culture and enrichment using Poly(epsilon-Caprolactone) Scaffolds. Molecules. 2016;21:537.
  • Rijal G, Bathula C, Li W. Application of synthetic polymeric scaffolds in breast cancer 3D tissue cultures and animal tumor models. Int J Biomater. 2017;2017:8074890.
  • Azimi B, Nourpanah P, Rabiee M, et al. Poly (epsilon-caprolactone) fiber: An overview. J Engin Fibers Fab. 2014;9:74–90.
  • Mondal D, Griffith M, Venkatraman SS. Polycaprolactone-based biomaterials for tissue engineering and drug delivery: Current scenario and challenges. Int J Polym Mat Polym Biomat. 2016;65:255–265.
  • Lam CX, Hutmacher DW, Schantz JT, et al. Evaluation of polycaprolactone scaffold degradation for 6 months in vitro and in vivo. J Biomed Mater Res A. 2009;90:906–919.
  • Shin M, Yoshimoto H, Vacanti JP. In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold. Tissue Eng. 2004;10:33–41.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.